W5's Jon Woodward reveals how one man dated and deceived multiple women while walking away with over $160,000 of their money.

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Here’s how it works. Let’s put aside the general dodginess of a product getting a CES Innovation Award despite not actually having been at the show itself and instead focus on the fact that LG must ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...